840 related articles for article (PubMed ID: 33931304)
1. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression.
Putri C; Hariyanto TI; Hananto JE; Christian K; Situmeang RFV; Kurniawan A
Parkinsonism Relat Disord; 2021 Jun; 87():155-161. PubMed ID: 33931304
[TBL] [Abstract][Full Text] [Related]
2. Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis.
Hariyanto TI; Putri C; Arisa J; Situmeang RFV; Kurniawan A
Arch Gerontol Geriatr; 2021; 93():104299. PubMed ID: 33285424
[TBL] [Abstract][Full Text] [Related]
3. Delirium is a good predictor for poor outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.
Hariyanto TI; Putri C; Hananto JE; Arisa J; Fransisca V Situmeang R; Kurniawan A
J Psychiatr Res; 2021 Oct; 142():361-368. PubMed ID: 34425488
[TBL] [Abstract][Full Text] [Related]
4. Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis.
Hariyanto TI; Kurniawan A
Sleep Med; 2021 Jun; 82():47-53. PubMed ID: 33892451
[TBL] [Abstract][Full Text] [Related]
5. Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression.
Hariyanto TI; Kurniawan A
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1662-1670. PubMed ID: 33838992
[TBL] [Abstract][Full Text] [Related]
6. Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression.
Hariyanto TI; Putri C; Frinka P; Louisa J; Lugito NPH; Kurniawan A
AIDS Res Hum Retroviruses; 2021 Jan; ():. PubMed ID: 33499744
[TBL] [Abstract][Full Text] [Related]
7. Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Hariyanto TI; Halim DA; Jodhinata C; Yanto TA; Kurniawan A
Clin Exp Pharmacol Physiol; 2021 Jun; 48(6):823-830. PubMed ID: 33719081
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and Parkinson's disease: a systematic review and meta-analysis.
Afraie M; Moradi G; Mohammadzedeh P; Azami M; Riyahifar S; Moradi Y
Acta Neurol Belg; 2023 Aug; 123(4):1209-1223. PubMed ID: 36385247
[TBL] [Abstract][Full Text] [Related]
9. Insulin Therapy and Outcome of Coronavirus Disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression.
Hariyanto TI; Lugito NPH; Yanto TA; Siregar JI; Kurniawan A
Endocr Metab Immune Disord Drug Targets; 2022; 22(5):481-489. PubMed ID: 34250875
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with COVID-19 in people with Parkinson's disease: a systematic review and meta-analysis.
Chambergo-Michilot D; Barros-Sevillano S; Rivera-Torrejón O; De la Cruz-Ku GA; Custodio N
Eur J Neurol; 2021 Oct; 28(10):3467-3477. PubMed ID: 33983673
[TBL] [Abstract][Full Text] [Related]
11. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W
J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266
[TBL] [Abstract][Full Text] [Related]
12. Exploring the relationship between novel Coronavirus pneumonia and Parkinson's disease.
Xi X; Han L
Medicine (Baltimore); 2022 Nov; 101(46):e31813. PubMed ID: 36401405
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease and COVID-19: a systematic review and meta-analysis.
Khoshnood RJ; Zali A; Tafreshinejad A; Ghajarzadeh M; Ebrahimi N; Safari S; Mirmosayyeb O
Neurol Sci; 2022 Feb; 43(2):775-783. PubMed ID: 34787753
[TBL] [Abstract][Full Text] [Related]
14. Epilepsy and the risk of severe coronavirus disease 2019 outcomes: A systematic review, meta-analysis, and meta-regression.
Siahaan YMT; Ketaren RJ; Hartoyo V; Hariyanto TI
Epilepsy Behav; 2021 Dec; 125():108437. PubMed ID: 34839246
[TBL] [Abstract][Full Text] [Related]
15. Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis.
Misra S; Kolappa K; Prasad M; Radhakrishnan D; Thakur KT; Solomon T; Michael BD; Winkler AS; Beghi E; Guekht A; Pardo CA; Wood GK; Hsiang-Yi Chou S; Fink EL; Schmutzhard E; Kheradmand A; Hoo FK; Kumar A; Das A; Srivastava AK; Agarwal A; Dua T; Prasad K
Neurology; 2021 Dec; 97(23):e2269-e2281. PubMed ID: 34635561
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
Sorrell L; Leta V; Barnett A; Stevens K; King A; Inches J; Kobylecki C; Walker R; Chaudhuri KR; Martin H; Rideout J; Sneyd JR; Campbell S; Carroll C;
PLoS One; 2023; 18(7):e0285349. PubMed ID: 37523365
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of hip arthroplasty in Parkinson's disease: a meta-analysis and systematic review.
Zhang Y; Chu SS; Liu K; Huang Q; Wang Y
Int Orthop; 2022 Apr; 46(4):705-716. PubMed ID: 34713326
[TBL] [Abstract][Full Text] [Related]
18. The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.
El-Qushayri AE; Ghozy S; Reda A; Kamel AMA; Abbas AS; Dmytriw AA
Rev Med Virol; 2022 Mar; 32(2):e2278. PubMed ID: 34260773
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis.
Hariyanto TI; Rosalind J; Christian K; Kurniawan A
South Afr J HIV Med; 2021; 22(1):1220. PubMed ID: 33936793
[TBL] [Abstract][Full Text] [Related]
20. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection.
Hariyanto TI; Kurniawan A
Diabetes Metab Syndr; 2020; 14(5):1463-1465. PubMed ID: 32771919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]